Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CETP | P11597 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | UBE2N | P61088 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31509114 | 1.00 | SPHK1 (0.48) | SPHK1ALDH1A1CYP2D6CYP3A4GMNN | |
| SCHEMBL31509014 | 1.00 | SPHK1 (0.48) | SPHK1ALDH1A1CYP2D6CYP3A4GMNN | |
| SCHEMBL317381 | 0.92 | SPHK1 (0.58) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL474319 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL11759808 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL10834948 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL6443782 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL11673194 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL4651557 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA | |
| SCHEMBL345181 | 0.90 | SPHK1 (0.61) | SPHK1CYP2D6CYP3A4GMNNLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108531315-A | A kind of adult's liquid detergent containing licorice | 内蒙古伊草恋生物科技有限责任公司 | 2018-09-14 | — | — | CN | claimed |
| US-9688838-B1 | Diisononyl terephthalate plasticizer and its use as well as process for producing the same | NAN YA PLASTICS CORPORATION (TW) | 2017-06-27 | — | — | US | claimed |
| US-20160201093-A1 | Process for the Bioconversion of C3-C13 Alkanes to C3-C13 Primary Alcohols | BASF SE (DE) | 2016-07-14 | — | — | US | claimed |
| EP-3027760-A1 | PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS | BASF SE (DE) | 2016-06-08 | — | — | EP | claimed |
| WO-2015014644-A1 | PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS | BASF SE (DE) | 2015-02-05 | — | — | WO | claimed |
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-12516147-B2 | Aldimines and uses thereof | BOSTIK SA (FR) | 2026-01-06 | — | — | US | disclosed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025096734-A1 | MICROCAPSULES | FMC CORPORATION (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-4077273-B1 | ALDIMINES AND USES THEREOF | BOSTIK SA (FR) | 2025-04-02 | — | — | EP | disclosed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | disclosed |
| US-4048330-A | Compositions containing 2-(6'-substituted-2'-naphthyl)acetic acid esters used for treating inflammation, pain or pyrexia | SYNTEX CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
| US-4009197-A | 2-(6-Substituted-2'-naphthyl) acetic acid derivatives and the salts and esters thereof | SYNTEX CORPORATION (PM) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | SPHK1 980/4885ALDH1A1 753/4885CYP2D6 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.